Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway

• Prif Awduron: Jie Zhao (Awdur), Ling Han (Awdur), Ya-Rong Zhang (Awdur), Shi-Meng Liu (Awdur), Deng-Ren Ji (Awdur), Rui Wang (Awdur), Yan-Rong Yu (Awdur), Mo-Zhi Jia (Awdur), San-Bao Chai (Awdur), Hui-Fang Tang (Awdur), Wei Huang (Awdur), Yong-Fen Qi (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2024-09-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Diabetic cardiomyopathy (DCM), one of the most serious long-term consequences of diabetes, is closely associated with myocardial fatty acid metabolism. Carnitine palmitoyltransferase-1β (CPT-1β) is the rate-limiting enzyme responsible for β-oxidation of long-chain fatty acids. Intermedin (IMD) is a...